mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
KIN001-260 |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.4 |
mRNA |
MS-275 |
GDSC1000 |
pan-cancer |
AAC |
-0.044 |
0.4 |
mRNA |
importazole |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
CEP-701 |
FIMM |
pan-cancer |
AAC |
0.11 |
0.4 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |